Komori
Astena Holdings (8095) · InitiativeAdvanced

Acquisition of 499,000 Treasury Shares

First written in FY2016-Q2. 2 of 7 entries say "Restated". Latest entry: FY2022.

7entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016-Q2 – FY2022-Q22016: 220162017: 120172018: 120182019: 020192020: 020202021: 020212022: 220222023: 1
Same theme, other companies
Flexible Shareholder Returns and Capital Policy Through Board AuthorityA theme 410 companies write about · 0 as a headwind · 411 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 199 companies compared. The sentences above are computed from all 199.Comparing 200 of the theme's 411 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2022AdvancedAnnual report

    「Treasury shares acquired during the fiscal year 676,400 shares ¥299,969,400」

    Based on the resolution of the Board of Directors dated 13 July 2022, the company acquired 676,400 treasury shares at an acquisition cost of ¥299,969,400.
  2. FY2022-Q3AdvancedAnnual report

    「At a meeting of the Board of Directors held on 13 July 2022, the company resolved to acquire treasury shares pursuant to Article 156 of the Companies Act, as applied with the necessary amendments under Article 165, paragraph 3, and acquired 474,800 treasury shares.」

    Based on the resolution of 13 July 2022, the company acquired 474,800 treasury shares. As a result of the acquisition, treasury shares increased by 497,962 to 518,376 at the end of the third quarter accounting period.
  3. FY2022-Q2Resolved to acquire additional treasury sharesAnnual report

    「At a meeting of the Board of Directors held on 13 July 2022, the company resolved matters relating to the acquisition of treasury shares pursuant to Article 156 of the Companies Act, as applied with the necessary amendments under Article 165, paragraph 3.」

    The company resolved to conduct market purchases from 14 July to 30 September 2022, with a limit of 900,000 common shares and a maximum total acquisition cost of ¥300 million, to enhance shareholder returns, improve capital efficiency and enable flexible capital policy.
  4. FY2017DroppedAnnual report

    「No applicable matters.」

    No new acquisition of treasury shares based on a Board of Directors' resolution was disclosed during the current fiscal year following the acquisition of 499,000 shares in the previous fiscal year.
  5. FY2016RestatedAnnual report

    「During the fiscal year, 499,000 treasury shares were acquired, leaving 1,000 shares under the acquisition resolution.」

    The annual disclosure confirmed that 499,000 shares were acquired against the resolution to acquire 500,000 shares, leaving 1,000 shares outstanding under the resolution.
  6. FY2016-Q3RestatedAnnual report

    「At a meeting of the Board of Directors held on 12 April 2016, the company resolved to acquire treasury shares pursuant to Article 156 of the Companies Act, as applied with the necessary amendments under Article 165, paragraph 3, and acquired 499,000 treasury shares.」

    The completion of the acquisition of 499,000 treasury shares was also confirmed in the notes on shareholders' equity.
  7. FY2016-Q2First statedAnnual report

    「At a meeting of the Board of Directors held on 12 April 2016, the company resolved to acquire treasury shares pursuant to Article 156 of the Companies Act, as applied with the necessary amendments under Article 165, paragraph 3, and acquired 499,000 treasury shares.」

    The company acquired 499,000 shares based on the Board of Directors' resolution, completing the acquisition on 26 April 2016.
Moved together

"Overseas Expansion and Product Development in Chemicals, New Equipment and Optimal-Site Production" moved the same way as this thread, in the same document, in 2 of its 7 moves.

222222★123456
  1. ★This thread
  2. 1Overseas Expansion and Product Development in Chemicals, New Equipment and Optimal-Site Production2×
  3. 2Expanding Sales of Generic Pharmaceutical Ingredients and New Materials Through Customer Proposals2×
  4. 3Developing New Customers, Proprietary Products and Overseas Customers Through the New Organization2×
  5. 4Slight Revenue Growth and Lower Profit for the HBC Business2×
  6. 5Strengthening Direct Marketing Through the Acquisition of All Shares in マルマンH&B2×
  7. 6Stable Supply of Pharmaceuticals, Capital Investment and Production Efficiency Improvements2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Astena Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Acquisition of 499,000 Treasury Shares | Astena Holdings Co.,Ltd. (8095) | Komori